In addition, there was also an increase in functional neuronal markers such as ChAT, α7nAChR, MAP2 and NEP genes, whereas BACE1 expression was significantly lowered in the drug-treated cells in comparison to AD-Neuro cells (Figure 5b). The gene discussed is BACE1; the disease is Alzheimer disease.